Screener
CRISPR Therapeutics CRSP Treasury Stock
Treasury Stock at other companies
Other financials
Where this comes from
Reported directly by CRISPR Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockValue.
The source filing: CRISPR Therapeutics’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:48 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204188
| Line item | As of / March 31, 2026 | As of / December 31, 2025 |
|---|---|---|
| Commitments and contingencies, see Note 7 | ||
| Shareholders’ equity: | ||
| Common shares, CHF 0.03 nominal value, 132,477,166 shares authorized at March 31, 2026 and at December 31, 2025, 96,500,822 and 96,009,657 shares issued at March 31, 2026 and December 31, 2025, respectively, 96,385,506 and 95,894,341 shares outstanding at March 31, 2026 and December 31, 2025, respectively | 3,115 | 3,087 |
| Treasury shares, at cost, 115,316 shares at March 31, 2026 and at December 31, 2025 | (60) | (60) |
| Additional paid-in capital | 3,883,924 | 3,861,516 |
| Accumulated deficit | (2,070,482) | (1,947,551) |
| Accumulated other comprehensive (loss) income | (1,941) | 4,821 |
| Total shareholders’ equity | 1,814,556 | 1,921,813 |
Item 1. Financial Statements
FAQ
- What is CRISPR Therapeutics's treasury stock?
- CRISPR Therapeutics (CRSP) reported treasury stock of $60K in Q1 2026.
- How has CRISPR Therapeutics's treasury stock changed year-over-year?
- CRISPR Therapeutics's treasury stock decreased by 3.2% year-over-year, from $62K to $60K.
- What is the long-term trend for CRISPR Therapeutics's treasury stock?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's treasury stock has grown at a -1.0% compound annual growth rate (CAGR), from $63K to $60K.
- What does treasury stock mean?
- Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.
Ask your AI about CRISPR Therapeutics's treasury stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude